STJ

1,186.5

-2.02%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,186.5

-2.02%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,186.5

-2.02%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,186.5

-2.02%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,186.5

-2.02%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

Search

GlaxoSmithKline PLC

Cerrado

SectorSanidad

1,841 -1.22

Resumen

Variación precio

24h

Actual

Mínimo

1838

Máximo

1856.25

Métricas clave

By Trading Economics

Ingresos

1.2B

1.8B

Ventas

-989M

7.6B

P/B

Media del Sector

13.387

49.8

BPA

0.465

Rentabilidad por dividendo

3.47

Margen de beneficios

24.105

Empleados

66,841

EBITDA

577M

2.8B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+8.02% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.47%

2.25%

Próximas Ganancias

29 jul 2026

Fecha Próximo Dividendo

9 jul 2026

Próxima Fecha de Ex Dividendo

14 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-4.2B

76B

Apertura anterior

1842.22

Cierre anterior

1841

Noticias sobre sentimiento de mercado

By Acuity

37%

63%

134 / 347 Clasificación en Healthcare

GlaxoSmithKline PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 abr 2026, 06:42 UTC

Ganancias

GSK Earnings Boosted by Higher Specialty Medicine Sales

6 may 2026, 13:35 UTC

Charlas de Mercado

GSK Is Taking Steps in Right Direction, But Might Need More -- Market Talk

29 abr 2026, 10:39 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

GSK CEO Sees RAPT Therapeutics Acquisition as Template for Future Deals -- Market Talk

29 abr 2026, 10:06 UTC

Charlas de Mercado
Ganancias

AstraZeneca, GSK Results Fail to Impress Market -- Market Talk

29 abr 2026, 10:02 UTC

Charlas de Mercado
Ganancias

GSK Makes Ideal Start for New CEO -- Market Talk

29 abr 2026, 06:07 UTC

Ganancias

GSK PLC Sees 70p 2026 Dividend Payout

29 abr 2026, 06:07 UTC

Ganancias

GSK PLC Declares Dividend of 17p

29 abr 2026, 06:07 UTC

Ganancias

GSK PLC Free Cash Flow of GBP0.8B

29 abr 2026, 06:06 UTC

Ganancias

GSK PLC Cash Generated From Operations GBP1.4B

29 abr 2026, 06:06 UTC

Ganancias

GSK PLC 1Q General Medicines Sales GBP2.3B

29 abr 2026, 06:06 UTC

Ganancias

GSK PLC 1Q Vaccines Sales GBP2.1B

29 abr 2026, 06:06 UTC

Ganancias

GSK PLC 1Q Specialty Medicines Sales GBP3.2B

29 abr 2026, 06:05 UTC

Ganancias

Analysts Saw GSK PLC 1Q Net Profit at GBP1.74B

29 abr 2026, 06:04 UTC

Ganancias

Analysts Saw GSK 1Q Adjusted Operating Profit of GBP2.46B

29 abr 2026, 06:04 UTC

Ganancias

GSK PLC 1Q Adjusted Operating Profit GBP2.65B

29 abr 2026, 06:04 UTC

Ganancias

Analysts Saw GSK PLC Core EPS of 43.3p

29 abr 2026, 06:04 UTC

Ganancias

Analysts Saw GSK PLC 1Q Turnover at GBP7.58B

29 abr 2026, 06:04 UTC

Ganancias

GSK PLC 1Q Adj EPS 46.50p

29 abr 2026, 06:01 UTC

Ganancias

GSK PLC Sees 2026 Adjusted EPS Growth of 7%-9%

29 abr 2026, 06:01 UTC

Ganancias

GSK PLC Sees 2026 Adjusted Oper Pft Growth of 7%-9%

29 abr 2026, 06:01 UTC

Ganancias

GSK PLC Sees 2026 Turnover Growth of 3%-5%

29 abr 2026, 06:01 UTC

Ganancias

GSK PLC Backs 2026 View

29 abr 2026, 06:00 UTC

Ganancias

GSK PLC 1Q EPS 42.6p

29 abr 2026, 06:00 UTC

Ganancias

GSK PLC 1Q Turnover GBP7.63B

29 abr 2026, 06:00 UTC

Ganancias

GSK PLC 1Q Pretax Pft GBP2.14B

29 abr 2026, 06:00 UTC

Ganancias

GSK PLC 1Q Oper Pft GBP2.29B

29 abr 2026, 06:00 UTC

Ganancias

GSK PLC 1Q Net Pft GBP1.74B

15 abr 2026, 06:12 UTC

Adquisiciones, fusiones, absorciones

GSK Completes Acquisition of 35Pharma

10 abr 2026, 10:43 UTC

Charlas de Mercado

GSK Could Report Weak General Medicines Results -- Market Talk

31 mar 2026, 14:02 UTC

Adquisiciones, fusiones, absorciones

Samsung Biologics Will Continue Supplying Products Previously Manufactured at Site to GSK Under Terms of Agreement

Comparación entre iguales

Cambio de precio

GlaxoSmithKline PLC previsión

Precio Objetivo

By TipRanks

8.02% repunte

Estimación a 12 Meses

Media 2,007.5 GBX  8.02%

Máximo 2,630 GBX

Mínimo 1,500 GBX

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GlaxoSmithKline PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

14 ratings

3

Comprar

8

Mantener

3

Vender

Sentimiento

By Acuity

134 / 347 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
help-icon Live chat